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Abstract Glycosaminoglycans (GAGs) are complexed with
plasma proteins and proteolysis of plasma reduced the protein^
GAG ratio about 140-fold. After dialysis, analysis by gradient
PAGE revealed heparinase-1-sensitive GAGs, thus suggesting
that heparin could be among the plasma GAGs. However, after
dialysis most of the plasma GAGs were still not ‘free’. PAGE of
peptides resistant to proteolysis showed high molecular weight
bands on the two sides of the dialysis membrane despite the 3.5
kDa molecular weight cut-off. Progressive dilution of the sample
allowed passage of peptides appearing as high molecular weight
bands in the diffusate. We interpret this phenomenon as the
presence of low molecular weight peptides that aggregate when
concentrated. Peptides on both sides of the membranes bound
heparin.
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1. Introduction
A major hindrance in characterizing plasma glycosamino-
glycans (GAGs) is their interaction with proteins [1]. Puri¢ca-
tion of GAGs from plasma is quite tedious and controversy
exists about the molecular species actually present and their
physiological role [2^4]. Heparin was detected in normal hu-
man plasma [5,6] and under pathological conditions [7^9].
Thus, it would be interesting to characterize the proteins
that bind GAGs in human plasma in order to ascertain
whether this binding might have a role in the maintenance
of hemostatic balance. Puri¢cation of GAGs from plasma
requires extensive proteolysis which yields 100% of circulating
GAGs in the supernatant of digested plasma [10]. However,
some peptides still co-purify with plasma GAGs as if they
were protected from proteolysis by association with GAGs
[6]. We hypothesize that these peptides may represent those
naturally interacting with plasma GAGs and we examined
their characteristics. Thus, the aim of this research is to begin
the characterization of those peptides that complex plasma
GAGs under physiological conditions and make their puri¢-
cation from plasma quite di⁄cult to reproduce.
2. Materials and methods
[3H]Heparin (speci¢c activity 440 WC/mg, MW 6.0^20.0 kDa) was
from New England Nuclear (Boston, MA, USA). Heparin EP 756
from bovine intestinal mucosa, low molecular weight heparin and
oligo-heparin were from Opocrin Research Laboratories (Modena,
Italy). Properties of heparins are reported in Table 1. The degree of
sulfation, expressed as molar ratio (Mr) of sulfate and carboxyl
groups, was determined by potentiometric analysis [11]. Activated
partial thromboplastin time (APTT) was measured as described [12].
Anti-activated coagulation factor X (AXa) activity was tested in a
chromogenic assay [13]. Chondroitin sulfate A, heparinase I (from
Flavobacterium heparinum, EC 4.2.2.7), heparitinase (heparan sulfate
lyase from F. heparinum, EC 4.2.2.8.) and chondroitinase ABC (EC
4.2.2.4) were from Sigma Chem. Co., St. Louis, MO, USA. Titan III
Zip Zone cellulose acetate plates were from Helena Laboratories
(Beaumont, TX, USA). Silver nitrate was from Merck (Darmstadt,
Germany), Azur A from BDH (Poole, UK) and Alcian blue from
Fisher Scienti¢c Co. (Pittsburgh, PA, USA). Reagents for SDS-
PAGE were from Bio-Rad (Hercules, CA, USA). Centricon concen-
trators (MW cut-o¡ 3.0 kDa) were from Amicon, Inc., Beverly, MA,
USA; dialysis membranes (MW cut-o¡ 3.5 kDa) were from Spectrum
(Breda, The Netherlands). Human plasma from the local blood bank
was subjected to proteolysis as described [6]. Protein concentration
was determined by the method of Bradford [14] using bovine serum
albumin as a standard. Hexuronic acid was measured as described
[15]. Cellulose acetate electrophoresis was performed at pH 1.0 [16].
2 Wl of aqueous solution of heparin of 13.0 kDa and chondroitin
sulfate at a concentration of 200 Wg/ml was used as standard. Aliquots
of 20 Wl of the plasma-derived samples were 10-fold concentrated and
analyzed by electrophoresis. SDS-PAGE was performed according to
Laemmli [17] and gels were stained with Coomassie brilliant blue.
Gradient PAGE was performed as described [18] and staining was
performed with Azur A and silver nitrate. 0.5 ml of the dialyzed
supernatant of digested plasma was lyophilized, solubilized in 100 Wl
of 0.1 M sodium acetate, 0.1 mM calcium acetate, pH 7.0 and incu-
bated with heparinase I (10 U) for 24 h at 37‡C. The sample was
dried, dissolved in 20 Wl of distilled water and analyzed on gradient
PAGE. The GAG content in the incubation mixture of digested plas-
ma with heparinase I, as determined according to Volpi et al. [5], was
approximately 5 Wg. Aliquots of 100 Wl of the dialyzed supernatant of
digested plasma were incubated at 37‡C for 24 h with the following
enzymes: chondroitinase ABC (0.1 U), heparinase I (2 U) and hep-
aritinase (0.1 U). Afterwards, the samples were dried, dissolved in
10 Wl of distilled water and 2 Wl was analyzed on cellulose acetate
electrophoresis. Aliquots of clear supernatant of digested plasma were
dialyzed against 10 or 100 volumes of distilled water using a Spectra-
pore membrane (cut-o¡ 3.5 kDa) for 24 h at 4‡C, or, alternatively,
were subjected to ultra¢ltration on Centricon membranes (cut-o¡
3.5 kDa). The sample was diluted with 10 or 100 volumes of distilled
water before centrifugation. The di¡usate, the ¢ltrate and the reten-
tate were collected, concentrated and analyzed on SDS-PAGE. After
dialysis of supernatant of digested plasma against 100 volumes of
distilled water, [3H]heparin binding experiments were performed on
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both di¡usate and retentate. Aliquots of 20 Wl of 0.1% human serum
albumin, 20 Wl of human plasma, 20 Wl of supernatant of digested
plasma, 20 Wl of the retentate, 2 ml of the di¡usate, were lyophilized,
dissolved in 100 Wl of phosphate bu¡ered saline (PBS), pH 7.4 and
incubated on 96-well microtiter plates overnight at 37‡C. The next
day, PBS was removed and the wells were preincubated with 100 Wl
of PBS, pH 7.4 containing 1% (w/v) human serum albumin for 30 min
at room temperature. We used human serum albumin instead of the
detergents to minimize non-speci¢c binding. The wells were rinsed
three times with the same bu¡er. [3H]Heparin binding was with
1U106 dpm/dish in 100 Wl of the binding bu¡er (1 WM [3H]heparin
(440 WC/mg) in PBS) containing 1% human serum albumin and 0.01%
sodium azide in the absence or presence of a 100-fold excess of un-
labelled ligand. Non-speci¢c binding was negligible (5% of total bind-
ing). After 2 h incubation at 37‡C, the coated plates were washed ¢ve
times with cold PBS (100 Wl), then solubilized in 4 M GdHCl over-
night at 37‡C. Radioactivity was determined by liquid scintillation
counting. Utilizing a Bio-Rad Model 422 Electro-Eluter, peptides
were electroeluted at room temperature from gel slices into 0.25 ml
of 0.025 M Tris, 0.192 M glycine, pH 8.3, 0.1% (w/v) SDS at the
cathode. Aliquots of the electroeluates were analyzed for amino acid
composition and sequencing. Amino acid analysis was performed on
6 M HCl hydrolysate using a Carlo Erba 3A29 Amino Acid Analyzer
with a computing integrator. Hydrolysis was carried out in vacuum-
sealed vials at 110‡C for 24 and 48 h. Values for Ser and Thr were
corrected for loss during hydrolysis. The Milligen Protein Sequencer
model 6600 was used for sequence determination.
3. Results and discussion
We previously reported that exhaustive proteolysis of mur-
ine plasma with a cocktail of proteases, released 100% of 35S
radioactivity from 35S-labelled plasma, thus demonstrating
that GAGs are complexed with plasma proteins [10]. Here,
we performed the same procedure using normal human plas-
ma. Results of a typical procedure of plasma digestion are: 20
ml of plasma containing 69.5 mg/ml of protein yielded 15 ml
of supernatant of digested plasma containing 0.66 mg/ml of
protein: the protein^GAG ratio was reduced about 140-fold.
This protein^GAG ratio derives from quanti¢cation of GAGs
as release of 35S radioactivity [10]; thus, classical determina-
tion of uronic acid content [15] was not feasible as the amount
of proteins prevented development of a reproducible colori-
metric reaction. However, these GAGs were not pure and
electrophoresis on cellulose acetate did not reveal GAGs co-
migrating with appropriate GAG standard (Fig. 1A). Gra-
dient PAGE (24^30%) was not feasible because of the pres-
ence of large amounts of small plasma molecules. Some of
these molecules could be removed by dialysis, which reduced
the protein content of the supernatant from 0.66 to 0.27 mg/
ml: gradient PAGE after dialysis revealed heparinase-1-sensi-
tive GAGs, suggesting that heparin could be among these
GAGs (Fig. 1B). However, even after dialysis, most of the
plasma GAGs were not ‘free’ as evidenced by cellulose acetate
electrophoresis (Fig. 1A). This ¢gure shows Alcian blue-pos-
itive bands migrating more slowly than standard GAGs, but
does not reveal any compound co-migrating with standard
heparins. These results could be explained considering that
GAGs co-purify with peptides that impair migration on cel-
lulose acetate electrophoresis; however, the selective entrap-
ping properties of 24^30% acrylamide separated peptides from
GAGs enabling indirect detection of heparin (Fig. 1B). A
silver stain-positive band at about 13 kDa was positive to
Coomassie blue (not shown) and it could represent peptides
stopped in acrylamide at the top of the running gel. These
results suggest that GAGs are non-covalently bound to plas-
Table 1
Properties of heparins used in the experiments
MW (kDa) SO3/COO3 (Mr) APTT (IU/mg) AXa (IU/mg)
EP 756 12.9 2.15 164 114
LMW 2123/850 4.5 2.19 37 86
Oligo-H 2000 2.1 2.03 1 50
Fig. 1. A: Cellulose acetate electrophoresis at pH 1.0 of the super-
natant of digested plasma before (a) and after dialysis (b) (the start-
ing samples were 10-fold concentrated before electrophoresis) ;
standard heparin (Hp) and chondroitin sulfate A (Cs) are run to-
gether in St; chondroitin sulfate A alone is in lane St1; St2, heparin
HP 756 (13.0 kDa); St3, low molecular weight heparin (4.5 kDa);
St4, oligo-heparin (2.0 kDa). B: Gradient PAGE (24^30%) and sil-
ver staining of standard heparins of di¡erent molecular weights
(lanes 1^3) and of supernatant of digested plasma after dialysis
(lane 5) (0.5 ml was concentrated at 20 Wl for suitable application
on the gel). Lane 1: standard heparin-derived oligosaccharides (4
Wg), mean MW 2.0 kDa; lane 2: standard low molecular weight
heparin (4 Wg), mean MW 4.5 kDa; lane 3: standard heparin EP
756 (10 Wg), mean MW 13.0 kDa; lane 4: sample 5 treated with
heparinase I; lane 6: standard heparin EP 756 treated with heparin-
ase I.
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ma peptides. Fig. 2 shows sensitivity to chondroitinase ABC
and heparinase I of the band migrating more slowly than
standard chondroitin sulfate in cellulose acetate electrophore-
sis. Densitometric analysis revealed an approximately 40%
decrease after treatment with each enzyme suggesting that
the highly sulfated GAGs in human plasma [5] were slowed
by interacting peptides, thus co-migrating together with
undersulfated chondroitin sulfate. A material positive to Pon-
ceau red staining was detectable in cellulose acetate electro-
phoresis in proximity of the starting point of application (not
shown).
We analyzed on SDS-PAGE the protein material of di-
gested plasma, the material retained by the dialysis membrane
and the dialyzed material (Fig. 3A); high MW bands were
evident on the two sides of the membrane despite the 3.5
kDa MW cut-o¡. The protein content ratios between retentate
and di¡usate were 3 and 0.4 respectively in sample dialyzed
against 10 or 100 volumes of water indicating that dilution
favored di¡usion of peptides. The band of supposedly 56 kDa
decreased in the retentate of the diluted sample and was de-
tectable in the di¡usate where no peptides of low MW could
be detected; the band at 20 kDa did not appear to cross the
membrane. We repeated the same experiment using a Centri-
con concentrator with the same MW cut-o¡, but at di¡erent
dilutions of the sample. Fig. 3B shows that dilution allowed
Fig. 2. Cellulose acetate electrophoresis at pH 1.0. St1, St treated
with chondroitinase ABC; St2, St treated with heparinase I; a, the
dialyzed supernatant of digested plasma; b, a treated with chondroi-
tinase ABC; c, a treated with heparitinase; d, a treated with hepa-
rinase I; St, low molecular weight heparin (LMWHP) and chondroi-
tin sulfate A (Cs).
Fig. 3. A: SDS-PAGE (15%) of supernatant of digested plasma be-
fore (s) and after dialysis against 10 volumes (b) or 100 volumes
(b1) of distilled water. Lanes a and a1 show the peptides in di¡u-
sate of samples b and b1. Lanes s, a, a1, b and b1 contained respec-
tively 20 Wg, 16 Wg, 20 Wg, 50 Wg and 13 Wg of protein in the follow-
ing volumes: 30 Wl, 1.0 ml, 5 ml, 0.1 ml and 50 Wl. Each sample
was lyophilized and dissolved in 20 Wl of distilled water for applica-
tion on the gel. B: SDS-PAGE (15%) of supernatant of digested
plasma subjected to ultra¢ltration on a Centricon membrane. Lanes
a, b and c show the electrophoretic pattern of peptides in the re-
tained fraction of undiluted sample (a), and of sample diluted 10-
fold (b) and 100-fold (c). Lanes a1, b1 and c1 show the peptides in
the ¢ltrate fraction of undiluted sample (a1), and of the sample di-
luted 10-fold (b1) and 100-fold (c1). After centrifugation, the vol-
ume of the retentate was reduced to 50% of the starting sample. 15
Wl of starting sample was used in lanes a and a1, 100 Wl in lanes b
and b1, 1 ml in c and c1. Each sample was lyophilized and dis-
solved in 20 Wl distilled water for application on the gel. Lanes a, b,
c and c1 contained respectively 20 Wg, 15 Wg, 9 Wg and 6 Wg of pro-
tein. In samples loaded on lanes a1 and b1 protein content was un-
detectable. St, standard proteins: phosphorylase B (97 kDa), bovine
serum albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase
(31 kDa), trypsin inhibitor (21.5 kDa), lysozyme (14 kDa).
Table 2
Amino acid composition
Amino acid Residue %
Aspartic acid 10.8
Serine 2.8
Proline n.d.
Alanine 4.5
Methionine 1.4
Leucine 9.1
Phenylalanine 5.8
Histidine 2.8
Tryptophan n.d.
Threonine 2.3
Glutamic acid 17.0
Glycine 21.1
Valine 4.6
Isoleucine 5.7
Tyrosine 2.8
Lysine 6.2
Arginine 3.4
Total 100.3
Results are expressed as amino acid residue %. Values for Ser and
Thr were determined by hydrolysis at 110‡C for 24 and 48 h in du-
plicate and extrapolated to zero time.
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passage of peptides that appeared as high MW bands on SDS-
PAGE. We interpret these data as the presence of low MW
peptides that aggregate when concentrated; they pass through
the dialysis membrane, but they pass through Centricon only
if diluted. Because SDS-PAGE required concentration, these
peptides passed through the membrane might re-aggregate
and appear as high MW bands. Peptides could aggregate de-
spite denaturing conditions because they are ‘protected’ by
highly negatively charged GAGs of low MW passing through
the membrane (not shown). Peptides on both sides of the
dialysis membrane bound heparin (Fig. 4). We suggest that
aliquots of peptides bound to heparin retained by the mem-
brane were not removed by dialysis and were responsible for
the impairment of heparin migration in cellulose acetate elec-
trophoresis (Fig. 1A). The band of apparent high MW (56
kDa), able to ‘pass through’ the dialysis membrane, was elec-
troeluted and analyzed in terms of amino acid content and
sequence; Table 2 shows the amino acid composition of this
material. Sequence determination was unsuccessful: no specif-
ic pattern was observed as if there was a variety of peptides
with di¡erent MW
In conclusion, we demonstrate that GAGs from normal
human plasma associated with peptides that aggregate when
concentrated. Some of these peptides were removed by dialy-
sis, as if their assembly was dependent on concentration and
appeared resistant to SDS. We hypothesize that they are part
of native supramolecular structure(s) in which GAGs, includ-
ing heparin, are vehicled in human plasma; alternatively, they
could be generated by proteolysis of plasma proteins. Dilution
of these peptides with loss of aggregation might play a role in
the interaction between GAGs and endothelial cells [16] or
platelets where dilution causes the release of heparin [19].
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Fig. 4. [3H]Heparin binding to plasma-derived fractions. Binding ex-
periments were performed on 96-well plastic cell culture dishes
coated with 20 Wl of 0.1% human serum albumin (1), 20 Wl of undi-
gested plasma (2), 20 Wl of the supernatant of the digested plasma
(3), 20 Wl of the retentate (4) and 2 ml of the di¡usate against 100
volumes of distilled water for 24 h at 4‡C, which was previously
lyophilized and then dissolved in 20 Wl (5). Samples 3, 4 and 5 con-
tained respectively 15 Wg, 6 Wg and 9 Wg of protein. Results are
means þ S.D. of triplicate samples. This experiment is representative
of three others which gave qualitatively identical results.
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